help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on August 5, 2008
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2008-1017
A more recent version of this article appeared on October 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
93/10/3748    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Kosmala, W.
Right arrow Articles by Marwick, T. H
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kosmala, W.
Right arrow Articles by Marwick, T. H
Related Collections
Right arrow Diabetes and Insulin
Right arrow Female Endocrinology
Right arrow Obesity

Submitted on May 12, 2008
Accepted on July 24, 2008

Subclinical Impairment of Left Ventricular Function in Young Obese Women: Contributions of Polycystic Ovary Disease and Insulin Resistance

Wojciech Kosmala MD, PhD, Trisha O'Moore Sullivan MBBS, FRACP, Rafal Plaksej MD, Justyna Kuliczkowska-Plaksej MD, Monika Przewlocka-Kosmala MD, and Thomas H Marwick MBBS, PhD*

Department of Cardiology, Wroclaw Medical University, Poland; Department of Endocrinology, Wroclaw Medical University, Poland; School of Medicine, University of Queensland, Brisbane, Australia

* To whom correspondence should be addressed. E-mail: t.marwick{at}uq.edu.au.

Context: Obesity and insulin resistance (IR) may produce disturbances of left ventricular (LV) function. Obese women with polycystic ovary syndrome (PCO), characterized by hormonal and metabolic abnormalities, are thought to be at particularly increased cardiovascular risk.

Objectives: We sought to determine the influence of IR on LV function in obese young women with and without PCO and without other comorbities.

Design: Prospective, cross-sectional study.

Setting: University hospital.

Patients: 150 women aged <40 years with body mass index (BMI)≥30kg/m2 classified into 3 groups: with PCO and IR and 2 groups without PCO: one with and the other without IR.

Main outcome measures: Tissue Doppler-derived myocardial velocities, strain-rate and strain, metabolic and hormonal measurements.

Results: Subclinical impairment of LV systolic and diastolic function as indicated by lower peak strain (p<0.001), peak systolic strain rate (SRs) (p<0.001), peak early diastolic strain rate (SRe) (p<0.001), and peak early diastolic velocity (p<0.01) were demonstrated in both groups with IR. IR subjects with and without PCO did not differ in any LV function indices. Strain was independently associated with fasting insulin ({beta}=-0.39,p<0.001), urinary albumin excretion (UAE) ({beta}=-0.36,p<0.001), and BMI ({beta}=-0.22,p<0.03), and SRe was associated with UAE ({beta}=-0.35,p<0.001), fasting insulin ({beta}=-0.24,p<0.02), BMI ({beta}=-0.23,p<0.02), and sex hormone-binding globulin (SHBG) ({beta}=0.20,p<0.04).

Conclusions: In obese young women, fasting insulin, BMI, SHBG and UAE are independent correlates of impaired LV performance. The contribution of PCO to LV function abnormalities is linked to IR, but not to other hormonal aberrations associated with this condition.


Key words: obesity • polycystic ovaries • insulin resistance • myocardial dysfunction • tissue Doppler and strain







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society